Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
Tillotson
G
G
Public Health Research Institute, New York, NY 10016, USA. gtillotson@fusionmdnetwork.com
Zhao
X
X
Drlica
K
K
D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D018432:Drug Resistance, Multiple; D006801:Humans; D015242:Ofloxacin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011018:Pneumonia, Pneumococcal / Q000097:blood / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000097:blood / Q000188:drug therapy*
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D015242:Ofloxacin